Jafron Biomedical Co Ltd (300529) - Cash Flow Conversion Efficiency

Latest as of September 2025: 0.010x

Based on the latest financial reports, Jafron Biomedical Co Ltd (300529) has a cash flow conversion efficiency ratio of 0.010x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥35.34 Million ≈ $5.17 Million USD) by net assets (CN¥3.43 Billion ≈ $501.72 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Jafron Biomedical Co Ltd - Cash Flow Conversion Efficiency Trend (2011–2024)

This chart illustrates how Jafron Biomedical Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. Read 300529 liabilities breakdown for a breakdown of total debt and financial obligations.

Jafron Biomedical Co Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Jafron Biomedical Co Ltd ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
Guodian Nanjing Automation Co Ltd SHG:600268	0.295x
Ashtrom Group Ltd TA:ASHG	0.027x
Mayora Indah Tbk JK:MYOR	0.058x
MeHow Innovative Ltd. A SHE:301363	N/A
Jiangzhong Pharmaceutical Co Ltd SHG:600750	-0.001x
OKE Precision Cutting Tools Co. Ltd. A SHG:688308	-0.006x
SPS Commerce Inc NASDAQ:SPSC	0.047x
DO & CO Aktiengesellschaft VI:DOC	0.150x

Annual Cash Flow Conversion Efficiency for Jafron Biomedical Co Ltd (2011–2024)

The table below shows the annual cash flow conversion efficiency of Jafron Biomedical Co Ltd from 2011 to 2024. For the full company profile with market capitalisation and key ratios, see Jafron Biomedical Co Ltd (300529) market capitalisation.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2024-12-31	CN¥3.33 Billion ≈ $487.97 Million	CN¥1.05 Billion ≈ $153.79 Million	0.315x	+8.39%
2023-12-31	CN¥3.15 Billion ≈ $461.36 Million	CN¥916.74 Million ≈ $134.15 Million	0.291x	+18.12%
2022-12-31	CN¥3.59 Billion ≈ $525.40 Million	CN¥883.80 Million ≈ $129.33 Million	0.246x	-33.34%
2021-12-31	CN¥3.38 Billion ≈ $495.13 Million	CN¥1.25 Billion ≈ $182.83 Million	0.369x	+9.28%
2020-12-31	CN¥2.83 Billion ≈ $414.65 Million	CN¥957.49 Million ≈ $140.11 Million	0.338x	+25.70%
2019-12-31	CN¥2.17 Billion ≈ $317.62 Million	CN¥583.50 Million ≈ $85.38 Million	0.269x	+20.52%
2018-12-31	CN¥1.72 Billion ≈ $251.97 Million	CN¥384.08 Million ≈ $56.20 Million	0.223x	+2.07%
2017-12-31	CN¥1.39 Billion ≈ $203.62 Million	CN¥304.10 Million ≈ $44.50 Million	0.219x	+44.85%
2016-12-31	CN¥1.18 Billion ≈ $173.26 Million	CN¥178.64 Million ≈ $26.14 Million	0.151x	-58.52%
2015-12-31	CN¥564.06 Million ≈ $82.54 Million	CN¥205.18 Million ≈ $30.02 Million	0.364x	+19.81%
2014-12-31	CN¥452.42 Million ≈ $66.20 Million	CN¥137.35 Million ≈ $20.10 Million	0.304x	-13.44%
2013-12-31	CN¥380.12 Million ≈ $55.62 Million	CN¥133.33 Million ≈ $19.51 Million	0.351x	-15.17%
2012-12-31	CN¥290.84 Million ≈ $42.56 Million	CN¥120.25 Million ≈ $17.60 Million	0.413x	+15.66%
2011-12-31	CN¥215.57 Million ≈ $31.54 Million	CN¥77.06 Million ≈ $11.28 Million	0.357x	--

About Jafron Biomedical Co Ltd

SHE:300529 China Medical Devices

Market Cap

$2.23 Billion

CN¥15.21 Billion CNY

Market Cap Rank

#5877 Global

#1245 in China

Share Price

CN¥19.04

Change (1 day)

-0.10%

52-Week Range

CN¥17.31 - CN¥24.54

All Time High

CN¥96.12